AI Biomarker Predicts BCG Rechallenge Efficacy in Non–Muscle-Invasive Bladder Cancer

An AI biomarker predicted which patients were not likely to benefit from bacillus Calmette-Guérin (BCG) reinduction after high- risk non–muscle- ...